Douglas Stapert

1.3k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

Douglas Stapert is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Douglas Stapert has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Douglas Stapert's work include Synthesis and biological activity (5 papers), Synthesis and Biological Evaluation (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Douglas Stapert is often cited by papers focused on Synthesis and biological activity (5 papers), Synthesis and Biological Evaluation (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). Douglas Stapert collaborates with scholars based in United States. Douglas Stapert's co-authors include Charles W. Ford, Judith C. Hamel, Michael R. Barbachyn, Douglas K. Hutchinson, Gary E. Zurenko, Betty H. Yagi, Ronda D. Schaadt, Michaël Génin, Kevin C. Grega and Daniel Emmert and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Trends in Microbiology.

In The Last Decade

Douglas Stapert

11 papers receiving 1.0k citations

Hit Papers

Substituent Effects on the Antibacterial Activity of Nitr... 2000 2026 2008 2017 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms Haemophilus influenzae and Moraxella catarrhalis
    2000 662 citations Michaël Génin, David Anderson et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Stapert United States 11 784 418 224 80 65 11 1.1k
Judith C. Hamel United States 11 787 1.0× 415 1.0× 217 1.0× 100 1.3× 67 1.0× 13 1.1k
Stuart A. Garmon United States 6 929 1.2× 481 1.2× 208 0.9× 113 1.4× 61 0.9× 6 1.2k
Kevin C. Grega United States 11 1.2k 1.5× 618 1.5× 347 1.5× 161 2.0× 85 1.3× 13 1.6k
Hsu‐Tso Ho United States 15 293 0.4× 326 0.8× 370 1.7× 68 0.8× 69 1.1× 17 935
Christopher K. Murphy United States 15 486 0.6× 513 1.2× 126 0.6× 67 0.8× 98 1.5× 31 1.2k
Adel Rafai Far United States 15 297 0.4× 212 0.5× 166 0.7× 84 1.1× 85 1.3× 24 700
Peter R. Manninen United States 7 398 0.5× 291 0.7× 223 1.0× 111 1.4× 77 1.2× 10 775
Betty H. Yagi United States 12 837 1.1× 465 1.1× 402 1.8× 187 2.3× 174 2.7× 17 1.4k
W E Kohlbrenner United States 16 250 0.3× 587 1.4× 204 0.9× 105 1.3× 59 0.9× 19 891
Kelly S.E. Tanaka United States 11 169 0.2× 278 0.7× 156 0.7× 70 0.9× 58 0.9× 17 558

Countries citing papers authored by Douglas Stapert

Since Specialization
Citations

This map shows the geographic impact of Douglas Stapert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Stapert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Stapert more than expected).

Fields of papers citing papers by Douglas Stapert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Stapert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Stapert. The network helps show where Douglas Stapert may publish in the future.

Co-authorship network of co-authors of Douglas Stapert

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Stapert. A scholar is included among the top collaborators of Douglas Stapert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Stapert. Douglas Stapert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Thomasco, Lisa M., Robert C. Gadwood, Elizabeth A. Weaver, et al.. (2003). The synthesis and antibacterial activity of 1,3,4-Thiadiazole phenyl oxazolidinone analogues. Bioorganic & Medicinal Chemistry Letters. 13(23). 4193–4196. 54 indexed citations
2.
Johnson, Paul D., Paul A. Aristoff, Gary E. Zurenko, et al.. (2003). Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials. Bioorganic & Medicinal Chemistry Letters. 13(23). 4197–4200. 30 indexed citations
3.
Lee, Chi‐Sing, Michael R. Barbachyn, Kevin C. Grega, et al.. (2001). Carbon–carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria. Bioorganic & Medicinal Chemistry. 9(12). 3243–3253. 25 indexed citations
4.
Stapert, Douglas, et al.. (2000). Linezolid, critical characteristics. PubMed. 28(1). 60–4. 19 indexed citations
5.
Génin, Michaël, David Anderson, Michael R. Barbachyn, et al.. (2000). Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms Haemophilus influenzae and Moraxella catarrhalis. Journal of Medicinal Chemistry. 43(5). 953–970. 662 indexed citations breakdown →
6.
Génin, Michaël, Douglas K. Hutchinson, Jackson B. Hester, et al.. (1998). Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Potent Antibacterial Activity Against the Fastidious Gram-Negative Organisms Haemophilus influenzae and Moraxella catarrhalis. Journal of Medicinal Chemistry. 41(26). 5144–5147. 22 indexed citations
7.
Ford, Charles W., Judith C. Hamel, Douglas Stapert, et al.. (1997). Oxazolidinones: New antibacterial agents. Trends in Microbiology. 5(5). 196–200. 56 indexed citations
8.
Ford, Charles W., Judith C. Hamel, Daniel M. Wilson, et al.. (1996). In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infections. Antimicrobial Agents and Chemotherapy. 40(6). 1508–1513. 118 indexed citations
9.
Barbachyn, Michael R., Dana S. Toops, Kevin C. Grega, et al.. (1996). Synthesis and antibacterial activity of new tropone-substituted phenyloxazolidinone antibacterial agents 2. Modification of the phenyl ring — the potentiating effect of fluorine substitution on in vivo activity. Bioorganic & Medicinal Chemistry Letters. 6(9). 1009–1014. 15 indexed citations
10.
Barbachyn, Michael R., Dana S. Toops, Kevin C. Grega, et al.. (1996). Synthesis and antibacterial activity of new tropone-substituted phenyloxazolidinone antibacterial agents 1. Identification of leads and importance of the tropone substitution pattern. Bioorganic & Medicinal Chemistry Letters. 6(9). 1003–1008. 10 indexed citations
11.
Ford, Charles W., Judith C. Hamel, Douglas Stapert, & Robert J. Yancey. (1989). Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. Journal of Medical Microbiology. 28(4). 259–266. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith C. Hamel Breakdown of academic impact, for papers by Stuart A. Garmon Breakdown of academic impact, for papers by Kevin C. Grega Breakdown of academic impact, for papers by Hsu‐Tso Ho Breakdown of academic impact, for papers by Christopher K. Murphy Breakdown of academic impact, for papers by Adel Rafai Far Breakdown of academic impact, for papers by Peter R. Manninen Breakdown of academic impact, for papers by Betty H. Yagi Breakdown of academic impact, for papers by W E Kohlbrenner Breakdown of academic impact, for papers by Kelly S.E. Tanaka
Rankless by CCL
2026